Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Primary central nervous system lymphoma chemotherapy ====== ===== General information ===== For [[Primary central nervous system lymphoma]]: In non-[[AIDS]] cases, [[chemotherapy]] combined with [[XRT]] prolongs survival compared to [[XRT]] alone. ((DeAngelis LM, Yahalom J, Heinemann M-H, et al. Primary Central Nervous System Lymphomas: Combined Treatment with Chemotherapy and Radiotherapy. Neurology. 1990; 40:80–86)). ===== Methotrexate (MTX) ===== see [[Methotrexate for primary central nervous system lymphoma]]. ===== Rituximab ===== [[Rituximab]] is available since [[1997]] for the treatment of refractory systemic [[B-cell]] [[non-Hodgkin lymphoma]]. [[Intrathecal]]ly may be more effective for [[CD33]] + lymphomas. primary_central_nervous_system_lymphoma_chemotherapy.txt Last modified: 2024/06/07 02:59by 127.0.0.1